Figure 1
Figure 1. Synergy of HDAC1/2 and HDAC3 inhibitors in T cell lymphoma model H9

Synergy of HDAC1/2 and HDAC3 inhibitors in T cell lymphoma model H9

Close Modal

or Create an Account

Close Modal
Close Modal